Order Article Reprints

Rasmussen M, Alvik K, Kannen V, Olafsen NE, Erlingsson LAM, Grimaldi G, Takaoka A, Grant DM, Matthews J. Loss of PARP7 Increases Type I Interferon Signaling in EO771 Breast Cancer Cells and Prevents Mammary Tumor Growth by Increasing Antitumor Immunity. Cancers. 2023; 15(14):3689. https://doi.org/10.3390/cancers15143689

Rasmussen, Marit, Karoline Alvik, Vinicius Kannen, Ninni E. Olafsen, Linnea A. M. Erlingsson, Giulia Grimaldi, Akinori Takaoka, Denis M. Grant, and Jason Matthews. 2023. "Loss of PARP7 Increases Type I Interferon Signaling in EO771 Breast Cancer Cells and Prevents Mammary Tumor Growth by Increasing Antitumor Immunity" Cancers 15, no. 14: 3689. https://doi.org/10.3390/cancers15143689

Rasmussen, M., Alvik, K., Kannen, V., Olafsen, N. E., Erlingsson, L. A. M., Grimaldi, G., Takaoka, A., Grant, D. M., & Matthews, J. (2023). Loss of PARP7 Increases Type I Interferon Signaling in EO771 Breast Cancer Cells and Prevents Mammary Tumor Growth by Increasing Antitumor Immunity. Cancers, 15(14), 3689. https://doi.org/10.3390/cancers15143689